piriqualone has been researched along with quinazolines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gulati, OD; Gupta, AK; Makol, R; Raghunath, PR; Shah, DS | 1 |
Chenard, BL; Critchett, D; DeVries, KM; Ewing, FE; Ganong, AH; Guanowsky, V; Guhan, S; Guinn, MR; Huang, J; Kelly, K; Lazzaro, J; Menniti, FS; Pagnozzi, MJ; Seymour, PA; Staigers, TL; Welch, WM | 1 |
2 other study(ies) available for piriqualone and quinazolines
Article | Year |
---|---|
Neuromuscular blocking action of 2-(2-(3-pyridyl) vinyl)-3-0-tolyl-3, 4-dihydroquinazoline-4-one (SRC 909).
Topics: Abdominal Muscles; Acetylcholine; Animals; Anura; Atropine; Calcium; Carbachol; Cats; Choline; Cold Temperature; Dose-Response Relationship, Drug; Female; Gallamine Triethiodide; Glycols; In Vitro Techniques; Leg; Male; Methysergide; Morphine; Muscle Contraction; Muscles; Neuromuscular Blocking Agents; Pentolinium Tartrate; Phrenic Nerve; Physostigmine; Potassium Chloride; Pyridines; Quinazolines; Quinazolinones; Rats; Sciatic Nerve; Tubocurarine; Vinyl Compounds | 1974 |
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
Topics: Animals; Anticonvulsants; Binding, Competitive; Brain; Calcium; Disease Models, Animal; Inhibitory Concentration 50; Isomerism; Neuromuscular Blocking Agents; Protein Binding; Pyridines; Quinazolines; Quinazolinones; Rats; Receptors, AMPA; Seizures; Solubility; Structure-Activity Relationship; Synaptic Transmission | 2001 |